Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Hormonal Intrauterine Devices (IUDs) Market?

The market for hormonal intrauterine devices (IUDs) has experienced rapid expansion in its size over recent years. This market is projected to expand from $2.87 billion in 2025 to $3.18 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be attributed to several factors, including heightened awareness regarding family planning alternatives, the broadening scope of women’s reproductive healthcare programs, a growing inclination towards long-acting contraceptive methods, the widespread availability of hormone-releasing devices, and backing from various public health campaigns.

The market for hormonal intrauterine devices (iuds) is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the projection period include a heightened need for non-surgical birth control options, an elevated emphasis on managing menstrual health, broader availability in developing regions, increased funding for women’s health innovations, and advancements in hormone delivery systems. Key trends anticipated within the forecast timeframe encompass a greater uptake of low-dose hormonal iuds, an escalating desire for long-acting reversible birth control, a developing inclination towards frameless device configurations, an expansion of iud uses for therapeutic purposes, and a strengthened commitment to patient comfort and safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

Which Drivers Are Supporting The Rise Of The Hormonal Intrauterine Devices (IUDs) Market?

The escalating number of unwanted pregnancies is projected to fuel the expansion of the hormonal intrauterine devices market. Unwanted pregnancies are defined as conceptions that are not planned or desired at the time of their occurrence. These can arise from various factors, including contraceptive failure, inadequate access to birth control methods, incorrect application of contraception, or sexual violence. Restricted availability of effective contraception elevates the likelihood of unwanted pregnancies by diminishing individuals’ autonomy over their reproductive choices. Hormonal IUDs prove highly efficient in averting pregnancy, showing a failure rate of less than 1%. They offer prolonged protection, typically spanning 3 to 7 years based on the device type, and stand as a reliable option for those seeking to avoid unwanted pregnancies. As an illustration, in July 2025, the Society for Family Planning, a US-based professional organization, stated that the number of abortions climbed to 1.14 million in 2024, an increase from 1.05 million recorded in 2023. Therefore, the rise in unwanted pregnancies is a primary driver for the growth of the hormonal intrauterine devices market.

What Leading Segments Are Studied In The Hormonal Intrauterine Devices (IUDs) Market?

The hormonal intrauterine devices (iuds) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

What Trends Are Expected To Impact The Competitive Landscape Of The Hormonal Intrauterine Devices (IUDs) Market?

Leading companies in the hormonal intrauterine devices market are concentrating on developing advanced solutions, such as levonorgestrel intrauterine devices (IUDs), to mitigate menstrual bleeding and cramps. Levonorgestrel intrauterine devices (IUDs) are long-lasting birth control methods implanted in the uterus that steadily release the hormone levonorgestrel to avert pregnancy. For example, in October 2024, Medicines360, a US-based nonprofit organization, introduced Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device offers two primary benefits: up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive action derives from its capacity to thicken cervical mucus, thereby stopping sperm from accessing the uterus. For managing heavy bleeding, it operates by thinning the uterine lining, which aids in decreasing menstrual flow.

Which Leading Companies Dominate The Hormonal Intrauterine Devices (IUDs) Market Share?

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

How Does The Hormonal Intrauterine Devices (IUDs) Market Perform Across Major Global Regions?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hormonal Intrauterine Devices (IUDs) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company

Contraceptive Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Hormonal Contraceptives Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Gynecological Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company